Delivery Order SPE2DB20D2014-SPE2DB25FC02V

Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product, with a ceiling value of $2,601.43 and a period of performance through June 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has a ceiling value of $12,260.17 and a period of performance through July 2, 2025. The contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication, with a ceiling value of $8,666.46. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products including the drug FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has a ceiling value of $32,141.18 and is a firm fixed price arrangement with a performance period ending on June 13, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568689836 - FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has a firm fixed price of $6,754.57 and a period of performance ending on July 2, 2025. The contract is not set aside and was awarded on July 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided about any...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has a ceiling value of $43,978.23 and a period of performance through June 25, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product, with a ceiling value of $8,771.78. The contract is a firm fixed price delivery order, with a performance period ending on May 21, 2025. This contract is not set aside and was awarded on May 20, 2025. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,833.32, is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a pharmaceutical product. The contract has a period of performance through March 17, 2025 and is a firm fixed-price contract. No set-aside designation is mentioned. AmerisourceBergen holds a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,078.45 fixed-price contract is for the supply of the pharmaceutical product FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,749.98, is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FC02V
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product, with a firm fixed price of $2,601.43 and a period of performance through May 23, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract allows the company to supply a range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.

Generated 8/21/25, 10:04 AM